MITOCHONDRIAL FREE RADICALS AND AGING

线粒体自由基与衰老

基本信息

项目摘要

The proposed studies are based on the hypothesis that cellular and organ aging are, to a significant degree, the consequences of oxygen free radical-mediated mitochondrial aging or impairment resulting from the accumulation of mitochondrial DNA mutations. Despite much indirect evidence, there is, as yet, no direct proof of the mitochondrial hypothesis of aging. However, the ability to modulate the activity of Mn superoxide dismutase (MnSOD) within mitochondria by genetic means makes it possible to assess the role of oxygen free radicals generated by the mitochondria in the aging process. To achieve this modulation of MnSOD activity, mutant mice completely lacking in MnSOD and mice with a low level of MnSOD expression from a transgene bred into the MnSOD deficient stock will be used. The finding that fetal fibroblasts lacking MnSOD are sensitive to atmospheric oxygen and have a shorter replicative life span than normal cells indicates that intramitochondrial superoxide levels can be affected by alteration of MnSOD activity. Mutant mice lacking MnSOD quickly develop a dilated cardiomyopathy and metabolic acidosis and die within 10 days after birth. However, in Specific Aim I, chimeras composed of cells completely lacking MnSOD and wild type cells will be formed, and the survival of the MnSOD-deficient cells exposed to a high level of superoxide will be followed in several organs and in the brain. In this manner it will be possible to assess the vulnerability of different types of cells and of different regions of the brain to free- radical induced mitochondrial damage. In Specific Aim II, the effects of chronically increased exposure to intra-mitochondrial superoxide will be studied in appropriately constructed transgenic animals with 10-30% of normal MnSOD activity. The longevity of these animals will determined, and the long term effects on mitochondrial DNA and the electron transport system will be assessed. In addition, behavioral studies will be carried out to determine whether any changes observed in the brain are correlated with alterations in behavior. These studies represent a new and innovative approach to the direct examination of the role of oxygen free radicals in producing mitochondrial mutations and dysfunction and, in turn, organ and organismal aging. Evidence that mitochondrial free radicals are indeed involved in the aging process would constitute a basis for searching for therapeutic approaches to the modulation of oxygen free radical levels within mitochondria.
拟议的研究是基于细胞和器官的假设 衰老在很大程度上是无氧的后果 自由基介导的线粒体衰老或损害 线粒体DNA突变的积累。尽管间接很多 有证据,目前尚无直接证明线粒体 衰老的假设。但是,调节MN活性的能力 通过遗传手段在线粒体内的超氧化物歧化酶(MNSOD)使 可以评估由 线粒体在衰老过程中。实现MNSOD的调制 活性,MNSOD和小鼠完全缺乏突变小鼠 从繁殖到MNSOD缺乏的转基因的MNSOD表达水平 将使用库存。缺乏MNSOD的胎儿成纤维细胞的发现是 对大气中的氧气敏感,并具有较短的复制寿命 比正常细胞表明,室内超氧化物水平 可能会受到MNSOD活性改变的影响。突变小鼠缺乏 MNSOD迅速发展出扩张的心肌病和代谢性酸中毒 并在出生后10天内死亡。但是,在特定的目标I中,嵌合体 由完全缺乏MNSOD和野生型细胞组成的细胞将是 形成,以及暴露于高的MNSOD缺陷细胞的存活率 在几个器官和大脑中将遵循超氧化物的水平。 通过这种方式,可以评估 不同类型的细胞和大脑不同区域的自由 根本诱导的线粒体损伤。在特定的目标II中, 长期增加对线粒体超氧化物的接触将是 在适当构建的转基因动物中研究了10-30% 正常的MNSOD活性。这些动物的寿命将确定, 以及对线粒体DNA和电子的长期影响 运输系统将进行评估。此外,行为研究将 进行以确定大脑中是否观察到的任何变化 与行为改变相关。这些研究代表了 直接检查角色的新的和创新的方法 产生线粒体突变和 功能障碍,然后是器官和有机体衰老。证据 线粒体自由基确实参与了衰老过程 将构成寻找治疗方法的基础 线粒体内氧自由基水平的调节。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles J Epstein其他文献

Charles J Epstein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles J Epstein', 18)}}的其他基金

ACCELERATED RTMS TREATMENT FOR PARKINSON'S DISEASE COMORBID WITH DEPRESSION
加速 RTMS 治疗伴有抑郁症的帕金森病
  • 批准号:
    7603646
  • 财政年份:
    2006
  • 资助金额:
    $ 20.92万
  • 项目类别:
TRANSCRANIAL MAGNETIC STIMULATION FOR DEPRESSION IN PARKINSON'S DISEASE
经颅磁刺激治疗帕金森病抑郁症
  • 批准号:
    7376408
  • 财政年份:
    2005
  • 资助金额:
    $ 20.92万
  • 项目类别:
TRANSCRANIAL MAGNETIC STIMULATION FOR DEPRESSION IN PARKINSON'S DISEASE
经颅磁刺激治疗帕金森病抑郁症
  • 批准号:
    7376404
  • 财政年份:
    2005
  • 资助金额:
    $ 20.92万
  • 项目类别:
ACCELERATED RTMS TREATMENT FOR PARKINSON'S DISEASE COMORBID WITH DEPRESSION
加速 RTMS 治疗伴有抑郁症的帕金森病
  • 批准号:
    7376399
  • 财政年份:
    2005
  • 资助金额:
    $ 20.92万
  • 项目类别:
TRANSCRANIAL MAGNETIC STIMULATION FOR DEPRESSION IN PARKINSON'S DISEASE
经颅磁刺激治疗帕金森病抑郁症
  • 批准号:
    7198975
  • 财政年份:
    2005
  • 资助金额:
    $ 20.92万
  • 项目类别:
Transcranial Magnetic Stimulation for Depression in Parkinson's Disease
经颅磁刺激治疗帕金森病抑郁症
  • 批准号:
    7039696
  • 财政年份:
    2003
  • 资助金额:
    $ 20.92万
  • 项目类别:
Transcranial Magnetic Stimulation for Depression in Parkinson's Disease
经颅磁刺激治疗帕金森病抑郁症
  • 批准号:
    7039698
  • 财政年份:
    2003
  • 资助金额:
    $ 20.92万
  • 项目类别:
AGE RELATED DEGENERATION
与年龄有关的退化
  • 批准号:
    6372363
  • 财政年份:
    1998
  • 资助金额:
    $ 20.92万
  • 项目类别:
AGE RELATED DEGENERATION
与年龄有关的退化
  • 批准号:
    6532519
  • 财政年份:
    1998
  • 资助金额:
    $ 20.92万
  • 项目类别:
AGE RELATED DEGENERATION
与年龄有关的退化
  • 批准号:
    2866834
  • 财政年份:
    1998
  • 资助金额:
    $ 20.92万
  • 项目类别:

相似海外基金

MOLECULAR ANALYSIS OF DYSTROPHIC CARDIAC CALCIFICATION
营养不良性心脏钙化的分子分析
  • 批准号:
    2640025
  • 财政年份:
    1998
  • 资助金额:
    $ 20.92万
  • 项目类别:
MITOCHONDRIAL FREE RADICALS AND AGING
线粒体自由基与衰老
  • 批准号:
    6043082
  • 财政年份:
    1997
  • 资助金额:
    $ 20.92万
  • 项目类别:
MITOCHONDRIAL FREE RADICALS AND AGING
线粒体自由基与衰老
  • 批准号:
    2382524
  • 财政年份:
    1997
  • 资助金额:
    $ 20.92万
  • 项目类别:
MITOCHONDRIAL MUTAGENESIS & AGE-RELATED PATHOPHYSIOLOGY
线粒体诱变
  • 批准号:
    2732548
  • 财政年份:
    1993
  • 资助金额:
    $ 20.92万
  • 项目类别:
MITOCHONDRIAL MUTAGENESIS & AGE-RELATED PATHOPHYSIOLOGY
线粒体诱变
  • 批准号:
    2409848
  • 财政年份:
    1993
  • 资助金额:
    $ 20.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了